Search

Your search keyword '"Receptors, Chimeric Antigen immunology"' showing total 21 results
Start Over Descriptor "Receptors, Chimeric Antigen immunology" Publication Type Magazines
21 results on '"Receptors, Chimeric Antigen immunology"'

7. CAR T cells put the brakes on asthma.

Author

Lambrecht BN and Hammad H

Subjects
Humans, Animals, T-Lymphocytes immunology, Mice, Receptors, Antigen, T-Cell immunology, Receptors, Antigen, T-Cell metabolism, Asthma immunology, Receptors, Chimeric Antigen immunology, Receptors, Chimeric Antigen genetics, Immunotherapy, Adoptive methods
Published
2024
Full Text
View/download PDF

10. First CAR for multiple myeloma.

Author

O'Leary K

Subjects
Humans, B-Cell Maturation Antigen immunology, Immunotherapy, Adoptive, Multiple Myeloma therapy, Receptors, Chimeric Antigen immunology
Published
2021
Full Text
View/download PDF

11. [Combining CAR-T cells anti-tumoral activity with exosomes properties: an innovative approach to fight cancer].

Author

Fusilier Z and Ferran H

Subjects
Animals, Carcinogenesis immunology, Combined Modality Therapy methods, Combined Modality Therapy trends, Humans, Immunotherapy, Adoptive methods, Medical Oncology methods, Medical Oncology trends, Mice, Neoplasms immunology, Receptors, Chimeric Antigen genetics, Receptors, Chimeric Antigen immunology, Receptors, Chimeric Antigen metabolism, T-Lymphocytes metabolism, T-Lymphocytes transplantation, Tumor Escape genetics, Tumor Escape immunology, Exosomes transplantation, Immunotherapy, Adoptive trends, Neoplasms therapy, Therapies, Investigational methods, Therapies, Investigational trends
Published
2020
Full Text
View/download PDF

12. Multiple Myeloma: The CAR T-cell Therapy Landscape.

Subjects
Antineoplastic Agents, Immunological pharmacology, B-Cell Maturation Antigen immunology, Clinical Trials as Topic, Congresses as Topic, Drugs, Investigational pharmacology, Florida, Hematology, Humans, Multiple Myeloma immunology, Receptors, Chimeric Antigen immunology, Societies, Medical, Treatment Outcome, Antineoplastic Agents, Immunological therapeutic use, B-Cell Maturation Antigen antagonists & inhibitors, Drugs, Investigational therapeutic use, Immunotherapy, Adoptive methods, Multiple Myeloma therapy
Abstract

BCMA-targeting chimeric antigen receptor T cells increasingly look like a potent option for multiple myeloma. Across several candidates spotlighted during the 2019 American Society of Hematology Annual Meeting, high response rates were seen in patients whose disease was refractory to multiple standard therapies., (©2020 American Association for Cancer Research.)

Published
2020
Full Text
View/download PDF

13. Cancer therapy returns to original target: HIV.

Author

Cohen J

Subjects
Animals, Cell Engineering, Humans, Mice, Receptors, Chimeric Antigen genetics, HIV immunology, Immunotherapy, Adoptive methods, Neoplasms therapy, Receptors, Chimeric Antigen immunology, T-Lymphocytes immunology, T-Lymphocytes transplantation
Published
2019
Full Text
View/download PDF

16. [IL-1RAP as a candidate for CAR T-cells immunotherapy].

Author

Neto Da Rocha M, Trad R, Warda W, Haderbache R, Bouquet L, Nicod C, Deschamps M, and Ferrand C

Subjects
Animals, Antibodies, Monoclonal genetics, Antigens, Neoplasm immunology, Biomarkers, Tumor genetics, Biomarkers, Tumor immunology, Biomarkers, Tumor metabolism, Caspase 9 genetics, Fusion Proteins, bcr-abl metabolism, Gene Expression Regulation, Neoplastic, Genes, Transgenic, Suicide, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism, Humans, Immunotherapy, Adoptive adverse effects, Interleukin-1 Receptor Accessory Protein genetics, Interleukin-1 Receptor Accessory Protein immunology, Killer Cells, Natural immunology, Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics, Leukemia, Myelogenous, Chronic, BCR-ABL Positive metabolism, Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology, Leukemia, Myeloid, Acute genetics, Leukemia, Myeloid, Acute metabolism, Leukemia, Myeloid, Acute therapy, Lymphocytes, Tumor-Infiltrating immunology, Lymphocytes, Tumor-Infiltrating transplantation, Mice, Mice, Inbred BALB C, Neoplasms metabolism, Precursor Cell Lymphoblastic Leukemia-Lymphoma metabolism, Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy, Receptors, Chimeric Antigen immunology, Antibodies, Monoclonal therapeutic use, Hematologic Neoplasms therapy, Immunotherapy, Adoptive methods, Interleukin-1 Receptor Accessory Protein metabolism, Lymphocytes, Tumor-Infiltrating metabolism, Receptors, Chimeric Antigen metabolism
Published
2019
Full Text
View/download PDF

17. Lymphoma: 4 big questions.

Author

Eisenstein M

Subjects
Allografts immunology, Circulating Tumor DNA blood, Early Detection of Cancer, Graft vs Host Disease immunology, Graft vs Host Disease therapy, Hodgkin Disease diagnosis, Hodgkin Disease drug therapy, Hodgkin Disease radiotherapy, Humans, Immunotherapy, Adoptive trends, Lymphoma complications, Lymphoma immunology, Lymphoma, Large B-Cell, Diffuse diagnosis, Lymphoma, Large B-Cell, Diffuse therapy, Prognosis, Receptors, Chimeric Antigen immunology, Recurrence, Stem Cell Transplantation adverse effects, T-Lymphocytes, Regulatory immunology, T-Lymphocytes, Regulatory transplantation, Graft vs Host Disease prevention & control, Hodgkin Disease therapy, Lymphoma diagnosis, Lymphoma therapy
Published
2018
Full Text
View/download PDF

18. CAR T-cells for relapsed B-cell ALL in adults.

Author

Gilbert JA

Subjects
Clinical Trials, Phase I as Topic, Humans, Immunotherapy, Adoptive adverse effects, Immunotherapy, Adoptive mortality, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma immunology, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma mortality, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma pathology, Receptors, Chimeric Antigen genetics, Recurrence, T-Lymphocytes immunology, Treatment Outcome, Immunotherapy, Adoptive methods, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma therapy, Receptors, Chimeric Antigen immunology, T-Lymphocytes transplantation
Published
2018
Full Text
View/download PDF

19. The market for chimeric antigen receptor T cell therapies.

Author

Yip A and Webster RM

Subjects
Hematologic Neoplasms immunology, Humans, Receptors, Antigen, T-Cell metabolism, Receptors, Chimeric Antigen metabolism, Hematologic Neoplasms therapy, Receptors, Antigen, T-Cell immunology, Receptors, Chimeric Antigen immunology, T-Lymphocytes immunology, T-Lymphocytes transplantation
Published
2018
Full Text
View/download PDF

20. CAR T-cells for relapsed B-cell ALL in children and young adults.

Author

Stirrups R

Subjects
Adolescent, Age Factors, Child, Child, Preschool, Clinical Trials, Phase II as Topic, Female, Humans, Immunotherapy, Adoptive adverse effects, Immunotherapy, Adoptive mortality, Male, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma immunology, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma mortality, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma pathology, Receptors, Chimeric Antigen genetics, Recurrence, T-Lymphocytes immunology, Treatment Outcome, Young Adult, Immunotherapy, Adoptive methods, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma therapy, Receptors, Chimeric Antigen immunology, T-Lymphocytes transplantation
Published
2018
Full Text
View/download PDF

21. First Chimeric Antigen Receptor T-Cell Therapy Approved.

Author

Brower V

Subjects
Humans, Neoplasms genetics, Neoplasms immunology, Receptors, Antigen, T-Cell genetics, Receptors, Chimeric Antigen genetics, T-Lymphocytes immunology, Treatment Outcome, Cell- and Tissue-Based Therapy, Neoplasms therapy, Receptors, Antigen, T-Cell immunology, Receptors, Chimeric Antigen immunology, T-Lymphocytes transplantation
Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results